Invasive Mold Disease Tied to High ICU and Ventilation Rates
Half of patients with invasive mold infections require mechanical ventilation, with significantly higher mortality observed in those with recent COVID-19.
Half of patients with invasive mold infections require mechanical ventilation, with significantly higher mortality observed in those with recent COVID-19.
The collaboration will focus on a point-of-care testing platform designed to detect tuberculosis from respiratory and blood samples.
The American Lung Association’s 2023 "State of Lung Cancer" report reveals improvement in five-year survival rate across the US, including for people of color.
Children's Hospital Los Angeles joined a trial to investigate nula-cel, a gene-editing therapy designed to correct the sickle cell disease genetic mutation.
Pediatric influenza and Mycoplasma pneumoniae infections returned to pre-pandemic levels after COVID-19 restrictions were lifted.
A proof-of-concept study showed an experimental monoclonal antibody targeting ARDS inflammation increased ventilator-free days and reduced organ failure.
Zidesamtinib (Jideytro) is approved for patients with ROS1-positive non-small cell lung cancer who have previously received targeted therapy.
The USFDA granted 510(k) clearance for the HoneyNaps Somnum V3.0 Ai-based software for polysomnography (PSG) analysis, according to the company.